EBS 14.55 -0.07 / Emergent Biosolutions News | Benzinga

Monday, May 21, 2012

Emergent BioSolutions Announces Stock Repurchase Program of up to $35M (EBS, News, Buybacks / Mon, 07:00am)

Tuesday, January 17, 2012

Emergent BioSolutions Subsidiary Announces Contract Modification (EBS, News, Contracts / Tue, 03:16pm)

Monday, January 09, 2012

Financial Breakfast: Morning News Summary for January 9, 2012 (ANF, BMY, Earnings, EBS, INHX, INSP, MR, News, NFLX, SPRD, TRV, Futures, Guidance, Upgrades, Commodities, Downgrades, Forex, Technicals, FDA, M&A, Events, Global, Econ #s, Economics, Pre-Market Outlook, Markets, Analyst Ratings, Tech, Trading Ideas, General / Mon, 08:26am)
Emergent BioSolutions Expects 2012 Revs $280-$300M vs $309M Est (EBS, News, Guidance / Mon, 08:02am)

Wednesday, December 28, 2011

A Peek Into The Market Before The Trading Starts (ABT, APP, CASC, EBS, KBR, News, STRM, Futures, Global, Pre-Market Outlook, Markets / Wed, 08:59am)
Emergent Announces Plans for TRU-016 Program Following Termination of Collaboration with Abbott (ABT, EBS, News, FDA / Wed, 08:00am)
Emergent Initiates Phase 2 Study of TRU-016 in Combination with Bendamustine in Patients with Relapsed Chronic Lymphocytic Leukemia (EBS, News, FDA / Wed, 08:00am)

Wednesday, December 21, 2011

Emergent BioSolutions Announces Fuad El-Hibri to Retire as CEO (EBS, News, Management / Wed, 03:00pm)

Thursday, December 01, 2011

Emergent BioSolutions Receives Orphan Drug Designation for Its TRU-016 Protein Therapeutic for the Treatment of Chronic Lymphocytic Leukemia (EBS, News, FDA / Thu, 08:04am)

Tuesday, November 29, 2011

WABCO Marks Another Industry First for Advanced Safety Technology in China as Part of Contract With Yutong, (ACC, EBS, ESC, News, WBC, Contracts, Global / Tue, 08:02am)

Thursday, November 17, 2011

Emergent BioSolutions Initiates Pivotal Clinical Trial Evaluating a Three-Dose BioThrax Regimen for Post-Exposure Prophylaxis (EBS, News, FDA / Thu, 07:53am)

Monday, October 03, 2011

Emergent BioSolutions Receives Award to Supply 44.75 Million Doses of BioThrax to U.S. Government over Five Years (EBS, News, Contracts, FDA / Mon, 07:01am)

Tuesday, September 27, 2011

Progress Software Reports Positive Quarter, Poor Guidance (Earnings, EBS, News, PRGS, Guidance, After-Hours Center / Tue, 04:40pm)

Friday, August 26, 2011

Results of Emergent BioSolutions Phase 1a Study on Adjuvanted BioThrax Anthrax Vaccine Published in the Journal Vaccine (EBS, News, FDA / Fri, 06:53am)

Wednesday, August 17, 2011

Emergent Announces Initiation of a Phase 1b/2 Study of TRU-016 in Combination with Rituximab and Bendamustine in Subjects with Relapsed - Indolent Lymphoma (EBS, News, FDA / Wed, 07:02am)

Thursday, June 09, 2011

Emergent BioSolutions' Investigational Anthrax Vaccine, NuThrax, Granted Fast Track Designation (EBS, News, FDA / Thu, 02:40pm)

Monday, June 06, 2011

A Peek Into The Market Before The Trading Starts (AAPL, AEO, BRNC, CHK, EBS, News, Futures, Global, Pre-Market Outlook, Markets / Mon, 07:30am)
Emergent BioSolutions Acquires Late-Stage Monoclonal Antibody Cancer Therapy from TenX BioPharma (EBS, News, M&A / Mon, 07:04am)

Thursday, May 26, 2011

Emergent Biosolutions Ticks over 15% Higher on Anticipated Government Agreement (EBS, News, Contracts, Movers / Thu, 01:20pm)

Monday, May 02, 2011

U.S. Government Expands BioThrax Procurement Contract to 17.92M Doses from 14.5M Increasing Contract Value by up to $101 Million (EBS) (EBS, News, Contracts / Mon, 04:42pm)

Friday, February 25, 2011

Emergent BioSolutions Announces that European Parliament Expresses Support for Rapid Development of New TB Vaccine (EBS, News, FDA / Fri, 11:52am)

Thursday, December 30, 2010

First California to Acquire Division of Palm Desert National Bank (EBS, FCAL, News, M&A / Thu, 04:30pm)

Monday, December 27, 2010

Emergent BioSolutions Starts Phase I Clinical Trial for Third Generation Anthrax Vaccine (EBS, News, Events / Mon, 05:32pm)

Friday, October 08, 2010

WellPoint Appoints Lori Beer as Executive Vice President (EBS, News, WLP, Management / Fri, 01:08pm)

Friday, September 17, 2010

Emergent BioSolutions Awarded Contract Valued at up to $186.6 Million (EBS) (EBS, HHS, News, Contracts / Fri, 01:16pm)

Friday, August 13, 2010

Benzinga’s Top Pre-Market NASDAQ Gainers (UNCA, PRXI, TRBN, VECO) (EBS, IBM, Long Ideas, News, PRXI, TRBN, UNCA, VECO, M&A, Pre-Market Outlook, Intraday Update, Markets, Movers, Trading Ideas / Fri, 09:19am)

Thursday, June 03, 2010

Top 5 Small-Cap Stocks In The Biotechnology Industry With The Highest Return On Equity (OMPI, MRX, AOB, EBS, SSRX) (AOB, Earnings, EBS, Long Ideas, MRX, News, OMPI, SSRX, Markets, Trading Ideas / Thu, 07:08am)